Skip to main content

BIO backpedals

Politics push biotech organization to withdraw heartland policy on GM crops.

Written byCharles Choi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Under pressure from a Corn Belt senator, biotechnology companies have dropped a self-imposed ban on growing pharmaceutical crops in heartland states only a month before the moratorium was scheduled to begin. "We do not wish to appear to encourage discrimination against any part of the country," Biotechnology Industry Organization (BIO) spokeswoman Lisa Dry said.

BIO members pledged in October to stop growing plants not intended for human or animal food in federally designated heartland areas, including Iowa, Illinois, Indiana and parts of Nebraska and five other states. The policy was set to take effect in 2003.

Since BIO first announced the voluntary ban, Senator Chuck Grassley (R-Iowa) worked to revise the policy, which he called "a hasty decision…based on a knee-jerk response to special interest groups instead of sound science," Grassley said in a statement issued last week. "Biotechnology has the potential to be a multimillion dollar industry for Iowa," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays